Ventana Medical Systems
Francisco Delgado is an experienced professional in the field of molecular diagnostics, currently serving as a Senior Project Leader for Companion Diagnostic Assays at Ventana Medical Systems since August 2006. Previously held various roles at Ventana Medical Systems, including Project Leader and Sr. Manager in Molecular Probe Development. Prior to this, Francisco Delgado was a Senior Research Associate and Project Analyst at Gen-Probe Incorporated from April 1998 to July 2006. Academic credentials include a Master of Business Administration from Point Loma University (2002-2004) and a Bachelor of Science in Molecular and Cellular Biology from the University of Arizona (1992-1997).
Ventana Medical Systems
Ventana Medical Systems, Inc., a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company’s intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, Ventana is driving personalized healthcare through accelerated drug discovery and the development of “companion diagnostics” to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.